New patent expiration for Braintree drug AXID

Annual Drug Patent Expirations for AXID Axid is a drug marketed by Smithkline Beecham, Braintree, and Glaxosmithkline and, and is included in three NDAs. There is one patent protecting this…

The post New patent expiration for Braintree drug AXID appeared first on DrugPatentWatch - Make Better Decisions.

Comments are closed.